Crossref
Metformin for the Prevention of Antipsychotic-Induced Weight Gain
The Journal of Clinical Psychiatry · 06.04.2026 · 87 (2)
DOI: 10.4088/jcp.25lr16260b ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Psychiatry, online erschienen am 06.04.2026. Verfasst von Charles Lung-Cheng Huang. Beteiligte Einrichtung: Department of Psychiatry, Chi Mei Medical Center, Tainan, Taiwan; and Department of Medicinal and Applied Chemistry, Kaohsiung Medical University, Ka….
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Psychiatry, Chi Mei Medical Center, Tainan, Taiwan; and Department of Medicinal and Applied Chemistry, Kaohsiung Medical University, Kaohsiung, Taiwan.
- Corresponding Author: Charles Lung-Cheng Huang, MD, PhD, Department of Psychiatry, Chi Mei Medical Center, 901, Chung Hwa Rd Yung Kang, Tainan, 710, Taiwan (psychidr@gmail.com).
Zitieren
APA
Huang, C. L. (2026). Metformin for the Prevention of Antipsychotic-Induced Weight Gain. The Journal of Clinical Psychiatry, 87(2). https://doi.org/10.4088/jcp.25lr16260b
Vancouver
Huang CL. Metformin for the Prevention of Antipsychotic-Induced Weight Gain. The Journal of Clinical Psychiatry. 2026;87(2). doi:10.4088/jcp.25lr16260b
BibTeX
@article{Huang2026,
author = {Huang, Charles Lung-Cheng},
title = {Metformin for the Prevention of Antipsychotic-Induced Weight Gain},
journal = {The Journal of Clinical Psychiatry},
year = {2026},
volume = {87},
number = {2},
doi = {10.4088/jcp.25lr16260b}
}
EUVIMED